Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Testa

Showing results (91-100 of 217) with videos related to

Pageof 22
Sort By:
Oncogene|June 10, 1998
Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulinD A Altomare, G E Lyons, Y Mitsuuchi, et al.
Cancer Research|July 14, 1998
Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporterK Lee, M G Belinsky, D W Bell, et al.
Cell|June 25, 1999
Absence of BCL10 mutations in human malignant mesotheliomaS Apostolou, A De Rienzo, S S Murthy, et al.
Cancer Research|March 1, 1992
Chromosome alterations in human small cell lung cancer: frequent involvement of 5qI Miura, S L Graziano, J Q Cheng, et al.
Genomics|January 1, 1988
The AKT1 proto-oncogene maps to human chromosome 14, band q32S P Staal, K Huebner, C M Croce, et al.
Oncogene|October 11, 2001
Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesotheliomaA De Rienzo, B R Balsara, S Apostolou, et al.
Genomics|July 1, 1988
Localization of the proto-oncogene MOS to 8q11-q12 by in situ chromosomal hybridizationJ R Testa, N Z Parsa, M M Le Beau, et al.
Blood|November 1, 1987
Minimally differentiated acute nonlymphocytic leukemia: a distinct entityE J Lee, A Pollak, R D Leavitt, et al.
Cancer Research|September 1, 1979
Evolution of karyotypes in acute nonlymphocytic leukemiaJ R Testa, U Mintz, J D Rowley, et al.
American Journal of Human Genetics|June 1, 1989
Cancer in relatives of leukemic patients with chromosomal rearrangements at rare (heritable) fragile-site locations in their malignant cellsE H Mules, J R Testa, G H Thomas, et al.
Pageof 22

Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
Oncogene|June 10, 1998
Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulinD A Altomare, G E Lyons, Y Mitsuuchi, et al.
Cancer Research|July 14, 1998
Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporterK Lee, M G Belinsky, D W Bell, et al.
Cell|June 25, 1999
Absence of BCL10 mutations in human malignant mesotheliomaS Apostolou, A De Rienzo, S S Murthy, et al.
Cancer Research|March 1, 1992
Chromosome alterations in human small cell lung cancer: frequent involvement of 5qI Miura, S L Graziano, J Q Cheng, et al.
Genomics|January 1, 1988
The AKT1 proto-oncogene maps to human chromosome 14, band q32S P Staal, K Huebner, C M Croce, et al.
Oncogene|October 11, 2001
Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesotheliomaA De Rienzo, B R Balsara, S Apostolou, et al.
Genomics|July 1, 1988
Localization of the proto-oncogene MOS to 8q11-q12 by in situ chromosomal hybridizationJ R Testa, N Z Parsa, M M Le Beau, et al.
Blood|November 1, 1987
Minimally differentiated acute nonlymphocytic leukemia: a distinct entityE J Lee, A Pollak, R D Leavitt, et al.
Cancer Research|September 1, 1979
Evolution of karyotypes in acute nonlymphocytic leukemiaJ R Testa, U Mintz, J D Rowley, et al.
American Journal of Human Genetics|June 1, 1989
Cancer in relatives of leukemic patients with chromosomal rearrangements at rare (heritable) fragile-site locations in their malignant cellsE H Mules, J R Testa, G H Thomas, et al.
Pageof 22